Answers are grounded in this paper and cite their sources.
Driving under the influence (DUI) of alcohol and drugs remains a major contributor to road deaths, yet comparable prevalence data are lacking in many countries. This study uses data from the third edition of the E-Survey of Road users’ Attitudes (ESRA3), collected in 2023 among more than 37,000 adults in 39 countries. It compares self-reported DUI, related norms and attitudes, support for policy measures and experienced enforcement among car drivers in Europe, the Americas and Asia-Oceania. Self-reported driving above the legal alcohol limit in the past 30 days ranged from 1.2% (Kyrgyzstan) to 24.1% (Luxembourg), and driving after taking drugs from 1.3% (Serbia) to 37.0% (Thailand). Personal acceptability of DUI was low in all countries, but respondents consistently believed that others were more accepting of drink-driving than they were themselves. Support for measures against drink-driving was high, with at least 62% in favour of each measure in every region. Experienced alcohol checks in the past 12 months ranged from 0.8% (Japan) to 41.6% (Serbia), while drug tests were far less common. Regional logistic regression models, adjusted for country and social desirability, showed that male gender, personal acceptability of drink-driving, high perceived behaviour control, a weak intention to refrain and low support for policy measures were consistently associated with self-reported drink-driving. For self-reported drug-driving, male gender, personal acceptability of drug-driving and, counter-intuitively, having been tested for drugs were associated with the behaviour in all regions, probably reflecting selective enforcement. In seven European countries, self-reported drink-driving correlated strongly with prevalence observed in roadside surveys (r = 0.933). Between ESRA2 and ESRA3, self-reported driving after drinking decreased in most countries, and experienced drug testing increased. The findings support the use of harmonised self-report surveys as a complement to roadside and crash data for monitoring DUI and for tailoring national countermeasures.
No takes yet. Share an insight, caveat, or question.
Meesmann et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: